Knowledge gleaned from the commercialization of Akkermansia muciniphila should lead to an accelerated path to market for a novel probiotic candidate for weight management, says the researcher behind both developments.
Supplementation with a novel bacterium isolated from the human gut may counteract diet-induced obesity, insulin resistance, and inflammation, says a new study that creates “an incredible scientific opportunity”.